SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 16.30 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 36.66 |
| Book Value / Share | 2.92 |
| Price / Book | n/a |
| NCAV ($M) | 3.13 |
| NCAV / Share | 0.25 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.44 |
| Return on Assets (ROA) | -0.22 |
| Return on Equity (ROE) | -0.33 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.74 |
| Current Ratio | 3.95 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 19.69 |
| Assets | 53.22 |
| Liabilities | 16.56 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 8.42 |
| Operating Income | -7.62 |
| Net Income | -17.12 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -2.92 |
| Cash from Investing | 4.40 |
| Cash from Financing | -0.86 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
Financial data and stock pages provided by
Fintel.io